Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
260,50 € ↑8,70 (3,46%)
2026-06-04
DEL PRIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
Institution683 Capital Management, LLC
Latest Disclosed Ownership21,000 shares
Latest Disclosed Value $ 6,948,270
683 Capital Management, LLC ownership in DUL / Alnylam Pharmaceuticals, Inc.

On May 15, 2026 - 683 Capital Management, LLC filed a 13F-HR form disclosing ownership of 21,000 shares of Alnylam Pharmaceuticals, Inc. (DE:DUL) valued at $5,999,700 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 3,782 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of 455.26% during the quarter. The current value of the position is $5,470,500 USD.

683 Capital Management, LLC has a history of taking positions in derivatives of the underlying security (DUL) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DUL / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 21,000 17,218 455.26 6,948 362.28 0.3626
2026-02-17 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 3,782 3,782 1,504 0.0654
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -39,000 -100.00 0 -100.00
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 39,000 -10,000 -20.41 5,688 -28.91 0.4017
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 49,000 0 0.00 8,001 -3.71 0.4283
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 49,000 0 0.00 8,309 -10.19 0.3057
2021-11-15 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 49,000 -6,000 -10.91 9,252 -0.77 0.3609
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 55,000 0 0.00 9,324 20.08 0.3221
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 55,000 -50,000 -47.62 7,765 -43.10 0.4109
2021-02-16 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 105,000 0 0.00 13,646 -10.74 0.6455
2020-11-16 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 105,000 0 0.00 15,288 -1.70 1.1197
2020-08-14 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 105,000 -65,000 -38.24 15,552 -15.95 1.2447
2020-05-15 2020-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 170,000 -55,000 -24.44 18,504 -28.59 2.1704
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 170,000 -55,000 18,504 2,185,740.7114
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 225,000 -129,000 -36.44 25,913 -8.98 2.9639
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 354,000 14,000 4.12 28,469 15.40 3.1656
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 340,000 14,000 4.29 24,670 -19.02 2.2437
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 326,000 0 0.00 30,465 28.17 2.7627
2019-02-15 2018-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 326,000 26,000 8.67 23,769 -9.47 1.4403
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 326,000 23,769
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 300,000 0 0.00 26,256 -11.14 1.7040
2018-09-17 2018-06-30 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 300,000 110,000 57.89 29,547 30.57 1.9965
2018-08-14 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 300,000 110,000 29,547
2018-05-15 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 190,000 -10,000 -5.00 22,629 -10.94 1.9997
2018-03-05 2017-12-31 13F/A-2 ALNYLAM PHARMACEUTICALS COM 02043Q107 200,000 -39,500 -16.49 25,410 -9.70 2.1421
2018-02-15 2017-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 200,000 0 25,410 2.1421
2017-12-07 2017-09-30 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 239,500 -30,500 -11.30 28,139 30.67 2.9569
2017-11-14 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 239,500 -30,500 28,139
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 270,000 0 0.00 21,535 55.62 3.1723
2017-05-15 2017-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 270,000 0 0.00 13,838 36.89 2.1500
2017-12-07 2016-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 270,000 150,000 125.00 10,109 24.28 0.7202
2017-02-14 2016-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 270,000 150,000 10,109
2016-11-14 2016-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 120,000 120,000 8,134 0.8637
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 128,100 -9.21 42,384 -24.46 n/a n/a n/a
2026-02-17 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 141,100 3.98 56,108 -9.33 n/a n/a n/a
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 135,700 -3.96 61,879 34.30 n/a n/a n/a
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 141,300 175.98 46,077 233.28 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 51,200 -12.78 13,825 0.09 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 58,700 -52.39 13,813 -59.27 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 123,300 0.33 33,911 13.55 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 122,900 243.30 29,865 458.21 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 35,800 5,350 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 10,000 1,771 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.